Astragaloside IV alleviates lipopolysaccharide‐induced preeclampsia‐like phenotypes via suppressing the inflammatory responses

Abstract Preeclampsia (PE) is a major cause of perinatal and maternal mortality and morbidity, which affects 2% to 8% of pregnancies in the world. The aberrant maternal inflammation and angiogenic imbalance have been demonstrated to contribute to the pathogenesis of PE. This research aimed to invest...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Dilihuma Tuerxun, Remila Aierken, Yan‐Mei Zhang, Ying Huang, Shuang Sui, Xiao‐Ying Li, Zulifeiya Abulikemu, Nuerbiye Dilixiati
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2021-03-01
Ráidu:	Kaohsiung Journal of Medical Sciences
Fáttát:	Astragaloside IV hypertension inflammation preeclampsia
Liŋkkat:	https://doi.org/10.1002/kjm2.12313
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!